6 Results

People

  1. Chiosis
    Chiosis
  2. Dao
    Dao
  3. Rodina Balingcongan
    Rodina Balingcongan
  4. Scheinberg
    Scheinberg
  5. Gomez
    Gomez
  6. Korontsvit
    Korontsvit
  7. Maslak
    Maslak
  8. May
    May
  9. Moulick
    Moulick
  10. Pinilla
    Pinilla

Groups

  1. Center for Hematologic Malignancies (6)
  2. GSK Faculty (6)
  3. Hematologic Malignancies Research (6)
  4. Molecular Pharmacology and Chemistry Program Faculty (6)
  5. Sloan Kettering Institute Faculty (6)
  6. Sloan Kettering Institute Postdocs (6)
  7. Adult Leukemia (3)
  8. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (3)
  9. Department of Medicine (3)
  10. Hematologic Malignancies, Division of (3)
  1. "Molecular Pharmacology and Chemistry Program Faculty"
  2. "2006"
  3. "Center for Hematologic Malignancies"
  4. "Sloan Kettering Institute Postdocs"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
Groups
  1. Center for Hematologic Malignancies (6)
  2. GSK Faculty (6)
  3. Hematologic Malignancies Research (6)
  4. Molecular Pharmacology and Chemistry Program Faculty (6)
  5. Sloan Kettering Institute Faculty (6)
  6. Sloan Kettering Institute Postdocs (6)

More Groups

People
  1. Anna Rodina Balingcongan (3)
  2. David Scheinberg (3)
  3. Gabriela Chiosis (3)
  4. Tao Dao (3)
  5. Javier Pinilla (2)
  6. Kamalika Moulick (2)

More People

Years
  1. 2006 (6)
Publications
  1. Anti-Cancer Agents in Medicinal Chemistry (1)
  2. Blood (1)
  3. Cancer Cell (1)
  4. EJC Supplements (1)
  5. Journal of Clinical Oncology (1)
  6. Leukemia Research (1)
Publishers
  1. American Society of Clinical Oncology (1)
  2. American Society of Hematology (1)
  3. Bentham Science Publishers (1)
  4. Cell Press (1)
  5. Elsevier Ltd (1)
  6. Pergamon-Elsevier Science Ltd (1)

Results (6)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD4+peptide epitopes from the WT1 oncoprotein stimulate CD4+and CD8+T cells that recognize and kill leukemia and solid tumor cells
    Meeting Abstract

    May, R. J.; Pinilla, J.; Korontsvit, T.; Zakhaleva, V.; Zhang, R. H.; Dao, T.; Maslak, P.; Scheinberg, D. A.
    Blood (2006)

    Fulltext@MSK | Save
  • Pilot trial of a synthetic breakpoint peptide vaccine in patients with chronic myeloid leukemia (CML) and minimal disease
    Meeting Abstract

    Maslak, P. G.; Dao, T.; Gupta, S.; Gomez, M.; Chanel, S.; Korontsvit, T.; Zakhaleva, V.; Ashraf, S.; Berman, E.; Scheinberg, D.
    Journal of Clinical Oncology (2006)

    Fulltext@MSK | Save
  • Defining Hsp90 as inhibitor of apoptosis in small cell lung cancer
    Meeting Abstract

    Chiosis, G.; Rodina, A.; Kim, J.; Aguirre, J.; Moulick, K.; Lopes, E. C.; Wu, N.; She, Y.
    EJC Supplements (2006)

    Fulltext@MSK | Save
  • Gene expression signature-based chemical genomic prediction identifies a novel class of HSP90 pathway modulators
    Journal Article

    Hieronymus, H.; Lamb, J.; Ross, K. N.; Peng, X. P.; Clement, C.; Rodina, A.; Nieto, M.; Du, J.; Stegmaier, K.; Raj, S. M.; more...
    Cancer Cell (2006)

    Fulltext@MSK | Save
  • Peptide binding motif predictive algorithms correspond with experimental binding of leukemia vaccine candidate peptides to HLA-A*0201 molecules
    Journal Article

    Gómez-Nuñez, M.; Pinilla-Ibarz, J.; Dao, T.; May, R. J.; Pao, M.; Jaggi, J. S.; Scheinberg, D. A.
    Leukemia Research (2006)

    Fulltext@MSK | Save
  • Emerging Hsp90 inhibitors: From discovery to clinic
    Journal Article

    Chiosis, G.; Rodina, A.; Moulick, K.
    Anti-Cancer Agents in Medicinal Chemistry (2006)

    Fulltext@MSK | Save